Tempus

(Senior) Medical Science Liaison - Sunbelt (US, Nashville)

Tennessee, United States

Not SpecifiedCompensation
Senior (5 to 8 years)Experience Level
Full TimeJob Type
UnknownVisa
Healthcare, Biotechnology, Precision MedicineIndustries

About Tempus

Passionate about precision medicine and advancing the healthcare industry? Recent advancements in underlying technology have finally made it possible for AI to impact clinical care in a meaningful way. Tempus' proprietary platform connects an entire ecosystem of real-world evidence to deliver real-time, actionable insights to physicians, providing critical information about the right treatments for the right patients, at the right time.

Role Overview

We are looking for a high-performing and experienced Medical Science Liaison (MSL) or Senior Medical Science Liaison (Sr. MSL) to support the commercial and educational objectives of the company. We are seeking a field-based MSL with a strong clinical and scientific background in oncology, genomic testing, and excellent communication skills to educate healthcare providers about Tempus assays and technologies. We are considering candidates residing in the Sunbelt territory, which supports the (LA, AL, MS, TN) regions of the US.

Responsibilities

  • Function as a sales and commercial team support and a regional expert with respect to Tempus oncology assays, promoting exchange of clinical/scientific/technical information with regional KOLs and other physicians in the field of oncology.
  • Facilitate education of a broader healthcare provider community within the region (KOLs, community physicians, medical directors, and other HCPs) regarding Tempus oncology products via in-person or virtual presentations. This will include proactive and reactive communication of scientific data.
  • Provide scientific education for internal stakeholders in collaboration with Learning & Development team.
  • Attend conferences and other key meetings and provide comprehensive meeting synopses and summaries of high-impact abstracts/posters/oral presentations.
  • Continuously update internal stakeholders on relevant medical and scientific knowledge as well as proactively sharing market intelligence.

Required Skills

  • Fundamental understanding of the field of molecular oncology and related patient management algorithms.
  • Existing KOL relationships in the field of oncology.
  • Working knowledge of genomic laboratory-developed testing (LDT); familiarity with CLIA-88’, CAP, Sunshine Act (2013).
  • Public speaking skills and ability to effectively communicate relevant scientific topics and concepts.
  • Exceptional interpersonal communication skills, strong inter-, and intradepartmental management skills, ability to educate and train.
  • Self-starter with an ownership mindset able to work and deliver on tight timelines.
  • Ability to travel (up to 50%).

Education and Experience

  • Advanced scientific or medical degree (PhD, PharmD, MD, MSN, BSN).
  • Basic understanding of oncology required; basic understanding of molecular testing strongly preferred.
  • 1+ years of MSL experience in diagnostics, biotech or pharmaceutical industries.

Equal Opportunity Employer

We are an equal opportunity employer. We do not discriminate on the basis of race, religion, color, national origin, gender, sexual orientation, age, marital status, veteran status, or disability status.

Skills

Oncology
Genomic Testing
Clinical Data
Scientific Data
Market Intelligence
Communication Skills
Presentation Skills

Tempus

AI-driven healthcare data analysis platform

About Tempus

Tempus focuses on enhancing patient outcomes through the use of data and artificial intelligence in healthcare. The company offers a platform that analyzes medical data to provide insights for physicians, helping them make better treatment decisions. This platform also aids pharmaceutical and biotech companies in drug development by identifying new targets and assessing treatment effectiveness. For patients, Tempus identifies personalized therapy options, particularly in cancer care, where their research has shown increased opportunities for tailored treatments. They have developed a pan-cancer organoid platform and a liquid biopsy assay for profiling circulating tumor DNA. Tempus generates revenue by charging healthcare providers and companies for access to their platform and insights, setting them apart from competitors by their focus on personalized medicine and extensive cancer research.

Chicago, IllinoisHeadquarters
2015Year Founded
$894.9MTotal Funding
IPOCompany Stage
AI & Machine Learning, Biotechnology, HealthcareIndustries
1,001-5,000Employees

Benefits

Relocation Assistance
Company Equity
Performance Bonus

Risks

Competition from partners like Genialis may lead to conflicts of interest.
Ambry Genetics acquisition could pose financial risks if synergies aren't realized.
Technical challenges may arise in integration with Flatiron's OncoEMR platform.

Differentiation

Tempus uses AI to analyze clinical and molecular data for precision medicine.
Their platform aids in personalized treatment decisions for cancer patients.
Tempus collaborates with biotech firms to enhance drug development using real-world data.

Upsides

Increased AI adoption in healthcare boosts Tempus' partnerships and collaborations.
Acquisition of Ambry Genetics expands Tempus' genetic testing capabilities.
Integration with Flatiron's OncoEMR enhances precision in cancer treatment plans.

Land your dream remote job 3x faster with AI